![Frontiers | Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of the Implementation of Public Health Policies on HTLV-1 in Brazil Frontiers | Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of the Implementation of Public Health Policies on HTLV-1 in Brazil](https://www.frontiersin.org/files/Articles/859115/fmed-09-859115-HTML/image_m/fmed-09-859115-g001.jpg)
Frontiers | Strengths, Weaknesses, Opportunities and Threats (SWOT) Analysis of the Implementation of Public Health Policies on HTLV-1 in Brazil
![Protecting against researcher bias in secondary data analysis: challenges and potential solutions | SpringerLink Protecting against researcher bias in secondary data analysis: challenges and potential solutions | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10654-021-00839-0/MediaObjects/10654_2021_839_Fig1_HTML.png)
Protecting against researcher bias in secondary data analysis: challenges and potential solutions | SpringerLink
![Conducting secondary analysis of qualitative data: Should we, can we, and how? - Nicole Ruggiano, Tam E Perry, 2019 Conducting secondary analysis of qualitative data: Should we, can we, and how? - Nicole Ruggiano, Tam E Perry, 2019](https://journals.sagepub.com/cms/10.1177/1473325017700701/asset/images/large/10.1177_1473325017700701-fig1.jpeg)
Conducting secondary analysis of qualitative data: Should we, can we, and how? - Nicole Ruggiano, Tam E Perry, 2019
![Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial - The Lancet Public Health Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial - The Lancet Public Health](https://www.thelancet.com/cms/asset/c3bcfd4e-5b81-4f3c-b0a9-af42775eab36/gr1.jpg)
Effectiveness and cost-effectiveness of a health systems intervention for latent tuberculosis infection management (ACT4): a cluster-randomised trial - The Lancet Public Health
![Best practices for the interpretation and reporting of clinical whole genome sequencing | npj Genomic Medicine Best practices for the interpretation and reporting of clinical whole genome sequencing | npj Genomic Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41525-022-00295-z/MediaObjects/41525_2022_295_Fig1_HTML.png)
Best practices for the interpretation and reporting of clinical whole genome sequencing | npj Genomic Medicine
![Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials - The Lancet Respiratory Medicine Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/asset/24f3ffbf-f37f-41d7-881e-6fc4a3b746ae/gr1.jpg)
Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials - The Lancet Respiratory Medicine
![Design and implementation of a highly accurate spatiotemporal monitoring and early warning platform for air pollutants based on IPv6 | Scientific Reports Design and implementation of a highly accurate spatiotemporal monitoring and early warning platform for air pollutants based on IPv6 | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-08416-5/MediaObjects/41598_2022_8416_Fig1_HTML.png)